Share:
Peer-Reviewed Publication
Eur J Radiol2026;204113169.August 22, 2026Journal Article

CCTA characterization of coronary atherosclerosis diffuseness and focality using FFR-CT and plaque burden: results from the PRECISE trial.

Ruurt A Jukema1, Pamela S Douglas2, John K Khoo3, Maros Ferencik4, Nick Curzen5, Jonathan R Weir-McCall6, Gregg W Stone7, Campbell Rogers8, Sarah Mullen9, Nicholas Ng10, Benjamin J W Chow11, Mark G Rabbat12, Pal Maurovich-Horvat13, Gianluca Pontone14, Vincent L Sorrell15, Michelle Kelsey16, Michael G Nanna17, Sreekanth Vemulapalli18, Daniel B Mark19, Jonathon Leipsic20,
1Department of Radiology, St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Electronic address: r.jukema@amsterdamumc.nl.
2Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States. Electronic address: pamela.douglas@duke.edu.
3Department of Radiology, St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada; Dept of Cardiology, St George Hospital, Sydney, Australia. Electronic address: john.khoo@health.nsw.gov.au.
4Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, United States. Electronic address: ferencik@ohsu.edu.
5University of Southampton, Southampton, the United Kingdom of Great Britain and Northern Ireland. Electronic address: nick.curzen@uhs.nhs.uk.
6Biomedical Engineering and Imaging Sciences, King's College London, London, the United Kingdom of Great Britain and Northern Ireland. Electronic address: jonathan.weir-mccall@kcl.ac.uk.
7Icahn School of Medicine, Mount Sinai Medical Center, New York City, NY, United States. Electronic address: gregg.stone@mountsinai.org.
8Heartflow, Mountain View, CA, United States. Electronic address: crogers@heartflow.com.
9Heartflow, Mountain View, CA, United States. Electronic address: smullen@heartflow.com.
10Heartflow, Mountain View, CA, United States. Electronic address: nng@heartflow.com.
11Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: bchow@ottawaheart.ca.
12Division of Cardiology, Loyola University Chicago, United States. Electronic address: MRABBAT@lumc.edu.
13Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary. Electronic address: maurovich.horvat.pal@semmelweis.hu.
14Centro Cardiologico Monzino IRCCS, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy. Electronic address: gianluca.pontone@cardiologicomonzino.it.
15Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, United States. Electronic address: v.sorrell@uky.edu.
16DUKE University, Durham, NC, United States. Electronic address: michelle.kelsey@duke.edu.
17Yale University, New Haven, CT, United States. Electronic address: michael.nanna@yale.edu.
18DUKE University Medical Center, Chapel Hill, NC, United States. Electronic address: sreekanth.vemulapalli@duke.edu.
19Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States. Electronic address: daniel.mark@duke.edu.
20Department of Radiology, St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: jonathon.leipsic@ubc.ca.

Abstract

INTRODUCTION: Coronary artery disease (CAD) on coronary computed tomography angiography (CCTA) is typically assessed using a dichotomous ≥ 50 % stenosis threshold. However, CAD diffuseness may also influence patient management and outcomes. The PRECISE trial provides high quality data to examine these relationships. METHODS AND RESULTS: In this PRECISE substudy, patients with stable suspected CAD…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.